ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $5,648,000 | +1.9% | 169,473 | +1.8% | 0.01% | 0.0% |
Q1 2015 | $5,541,000 | -16.8% | 166,496 | +2.2% | 0.01% | -28.6% |
Q4 2014 | $6,659,000 | +33.1% | 162,942 | +10.4% | 0.01% | +16.7% |
Q3 2014 | $5,002,000 | +17.7% | 147,655 | +17.1% | 0.01% | +20.0% |
Q2 2014 | $4,249,000 | -11.2% | 126,054 | -0.1% | 0.01% | -16.7% |
Q1 2014 | $4,784,000 | +35.3% | 126,195 | +4.2% | 0.01% | +20.0% |
Q4 2013 | $3,535,000 | -29.0% | 121,069 | -16.9% | 0.01% | -28.6% |
Q3 2013 | $4,982,000 | -2.3% | 145,672 | -5.7% | 0.01% | -12.5% |
Q2 2013 | $5,097,000 | – | 154,501 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |